cDNA
Insight Genetics Licenses St. Jude's Test for Bone Marrow Transplants
NEW YORK (GenomeWeb News) – Insight Genetics today announced an exclusive, worldwide licensing deal with St. Jude Children's Research Hospital for a genetic test to improve donor matching in bone marrow transplants.
Not Backing Down in BRCA Test Infringement Case, Ambry Slaps Myriad with Antitrust Countersuit
Premium
After being sued by Myriad Genetics for allegedly infringing its patents on BRCA1 and BRCA2 gene mutation testing, Ambry Genetics pushed back this week with its own countersuit accusing Myriad of antitrust violations.
Industry reactions to the US Supreme Court's decision to invalidate patents on isolated gene sequences were immediate and ranged from elation to disappointment.
Originally published April 16.
UPDATE: Appeals Court Decides Isolated DNA Patentable, Myriad's Analytical Method Claims Not
Premium
The appeals court decided that isolated gene sequences do not occur naturally and are therefore patentable, but invalidated Myriad's method claims that describe "comparing" or "analyzing" DNA sequences, deeming them abstract, mental steps.